<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=hypertension%26drug&amp;format=rss"><channel><title>hypertension&amp;drug - BingNews</title><link>http://www.bing.com/news/search?q=hypertension%26drug&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>hypertension&amp;drug</title><link>http://www.bing.com/news/search?q=hypertension%26drug&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Baxdrostat, a New BP Drug, Could Be a Game-Changer for Hypertension</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.aol.com%2flifestyle%2fbaxdrostat-bp-drug-could-game-140011992.html&amp;c=1631763525007755751&amp;mkt=en-us</link><description>With almost half of American adults living with high blood pressure, it makes sense that you'd want every possible tool in your arsenal to reduce your numbers and get your blood pressure into a ...</description><pubDate>Thu, 16 Apr 2026 14:00:00 GMT</pubDate><News:Source>AOL</News:Source><News:Image>http://www.bing.com/th?id=ONUT.HxpJI4NhL-UM8Hpaq88fHA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>675</News:ImageMaxHeight></item><item><title>Association Between Social Determinants of Health and Adherence to Antihypertensive Medications in US Patients With Uncontrolled, Treated Hypertension</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.ahajournals.org%2fdoi%2f10.1161%2fCIRCOUTCOMES.125.012932&amp;c=4899592880045835526&amp;mkt=en-us</link><description>BACKGROUND: Identifying and addressing barriers to antihypertensive medication adherence is critical for hypertension control. Relatively little is known about how social determinants of health (SDoH) ...</description><pubDate>Fri, 17 Apr 2026 02:53:00 GMT</pubDate><News:Source>AHA/ASA Journals</News:Source><News:Image>http://www.bing.com/th?id=ONUT.U776wc-SWlzS-G-bYq0uGQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>2844</News:ImageMaxWidth><News:ImageMaxHeight>3806</News:ImageMaxHeight></item><item><title>Kardigan hypertension drug tangles biomarker win with blood pressure miss in phase 2 trial</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.fiercebiotech.com%2fbiotech%2fkardigan-hypertension-drug-tangles-biomarker-win-blood-pressure-miss-phase-2-trial&amp;c=16637696337062238435&amp;mkt=en-us</link><description>Kardigan’s tonlamarsen reduced a key biomarker for hypertension in a phase 2 trial, but missed the study’s other goal of significantly reducing blood pressure. The biotech evaluated monthly 90 mg ...</description><pubDate>Mon, 30 Mar 2026 02:11:00 GMT</pubDate><News:Source>Fierce Biotech</News:Source></item><item><title>EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.aol.com%2farticles%2fexclusive-scienture-secures-hypertension-drug-144610360.html&amp;c=11494470729031413395&amp;mkt=en-us</link><description>Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Wednesday the formalization of multiple commercial group purchasing organization (GPO) agreements for its new drug, Arbli (losartan potassium) Oral ...</description><pubDate>Wed, 01 Oct 2025 07:46:00 GMT</pubDate><News:Source>AOL</News:Source></item><item><title>New drug shows promise for patients with high blood pressure</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fdiseases-and-conditions%2fnew-drug-shows-promise-for-patients-with-high-blood-pressure%2far-AA20k9Eb&amp;c=13872959355803637794&amp;mkt=en-us</link><description>A new drug could offer hope to millions struggling with high blood pressure that won’t respond to existing treatments.</description><pubDate>Tue, 07 Apr 2026 05:00:00 GMT</pubDate><News:Source>Welltica+ on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.RTFqEhnOzkSQL3B_GYUehg&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1000</News:ImageMaxWidth><News:ImageMaxHeight>667</News:ImageMaxHeight></item><item><title>Ace Therapeutics Launches Advanced Custom Hypertension Animal Models to Accelerate Hypertension Drug Discovery</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.dispatch.com%2fpress-release%2fstory%2f150334%2face-therapeutics-launches-advanced-custom-hypertension-animal-models-to-accelerate-hypertension-drug-discovery%2f&amp;c=8890135296729230689&amp;mkt=en-us</link><description>Ace Therapeutics announced custom animal models of hypertension, designed to help understand hypertension pathogenesis and develop diagnostic tools. NEW YORK, NY ...</description><pubDate>Fri, 20 Feb 2026 23:00:00 GMT</pubDate><News:Source>Columbus Dispatch</News:Source></item><item><title>1SCNX : EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,50...</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.benzinga.com%2fnews%2fhealth-care%2f25%2f10%2f47966068%2fexclusive-scienture-secures-purchase-agreements-healthcare-institutions&amp;c=7528634383803036515&amp;mkt=en-us</link><description>Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Wednesday the formalization of multiple commercial group purchasing organization (GPO) agreements for its new drug, Arbli (losartan potassium) Oral ...</description><pubDate>Wed, 01 Oct 2025 01:46:00 GMT</pubDate><News:Source>Benzinga.com</News:Source></item><item><title>Blood pressure drug recalled over cancer concerns. What it means for Ohioans</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2farticles%2fblood-pressure-drug-recalled-over-173425312.html&amp;c=3296921282355739335&amp;mkt=en-us</link><description>Add Yahoo as a preferred source to see more of our stories on Google. Over half a million bottles of prazosin hydrochloride capsules, a blood pressure medication, are being recalled over a ...</description><pubDate>Thu, 30 Oct 2025 10:35:00 GMT</pubDate><News:Source>Yahoo</News:Source></item><item><title>5 hypertension drugs couldn’t help him—but kicking this habit lowered his blood pressure for good</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fdiet%2f5-hypertension-drugs-couldn-t-help-him-but-kicking-this-habit-lowered-his-blood-pressure-for-good%2far-AA1StWDT&amp;c=13620231190593628139&amp;mkt=en-us</link><description>He was in good shape, but relying on energy drinks changed things. Reviewed by Dietitian Emily Lachtrupp, M.S., RD Quitting an energy drink habit helped a man lower his blood pressure when medicine ...</description><pubDate>Tue, 16 Dec 2025 14:45:00 GMT</pubDate><News:Source>MSN</News:Source></item><item><title>AstraZeneca's Hard To Control Hypertension Drug Advances, With FDA Decision Expected In 2026</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.benzinga.com%2fnews%2ffda%2f25%2f12%2f49186301%2fastrazenecas-hard-to-control-hypertension-drug-advances-with-fda-decision-expected-in-2026&amp;c=10528162695925976336&amp;mkt=en-us</link><description>On Tuesday, the U.S. Food and Drug Administration accepted AstraZeneca Plc's (NASDAQ: AZN) New Drug Application (NDA) for baxdrostat for adult patients with hard-to-control (uncontrolled or ...</description><pubDate>Wed, 03 Dec 2025 02:27:00 GMT</pubDate><News:Source>Benzinga.com</News:Source></item><item><title>Hypertension Drug Development: FDA Draft Guidance Outlines Recommendations</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3b38cedc248a3b95121f4522c5b14&amp;url=https%3a%2f%2fwww.raps.org%2fresource%2fhypertension-drug-development-fda-draft-guidance.html&amp;c=10598248906795529535&amp;mkt=en-us</link><description>The US Food and Drug Administration (FDA) on Friday issued draft guidance providing recommendations for sponsors looking to develop drugs to treat hypertension in patients already taking several other ...</description><pubDate>Thu, 12 Jul 2018 17:00:00 GMT</pubDate><News:Source>RAPS</News:Source></item></channel></rss>